Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Jun-24 9:01 PM View:  | Fairmount Funds Management ... Director | Cogent Biosciences, Inc. (COGT) | 10-Jun-24 | Option Exercise | 1,500,000 | -- | -- | 32% 4.73M to 6.23M | |
| 01-Apr-24 6:19 PM View: | Fairmount Funds Management ... Director | Cogent Biosciences, Inc. (COGT) | 28-Mar-24 | Acquisition (other) | 286,851 | -- | -- | 6% 4.73M to 5.01M | |
| 01-Apr-24 6:19 PM View: | Fairmount Funds Management ... Director | Cogent Biosciences, Inc. (COGT) | 28-Mar-24 | Disposition (other) | 286,851 | -- | -- | (6%) 5.01M to 4.73M | |
| 16-Feb-24 6:43 PM View: | Fairmount Funds Management ... 10% Owner | Cogent Biosciences, Inc. (COGT) | 16-Feb-24 | Grant | 1,166,670 | $7.50 | $8,750,000.00 | 33% 3.56M to 4.73M | |
| 13-Jun-23 4:07 PM View: | Fairmount Funds Management ... 10% Owner | Cogent Biosciences, Inc. (COGT) | 09-Jun-23 | Purchase | 800,000 | $12.00 | $9,600,000.00 | 29% 2.76M to 3.56M | |
| 01-Jul-22 9:19 AM View: | Sachs Jessica Chief Medical Officer | Cogent Biosciences, Inc. (COGT) | 30-Jun-22 | Grant | 622 | $7.39 | $4,599.69 | 100% 0 to 0.62K | |
| 21-Jun-22 10:02 AM View: | Fairmount Funds Management ... 10% Owner | Cogent Biosciences, Inc. (COGT) | 16-Jun-22 | Market Purchase | 1,200,000 | $8.25 | $9,900,000.00 | 77% 1.56M to 2.76M | 1% |
| 04-Jan-22 9:25 PM View: | Sachs Jessica Chief Medical Officer | Cogent Biosciences, Inc. (COGT) | 31-Dec-21 | Grant | 674 | $6.82 | $4,594.66 | 100% 0 to 0.67K | |
| 28-Apr-21 8:30 PM View: | Green John L. Chief Financial Officer | Cogent Biosciences, Inc. (COGT) | 26-Apr-21 | Market Sale | 17,813 | $8.86 | $157,823.00 | (82%) 21.65K to 3.84K | 4% |
| 01-Mar-21 9:56 PM View: | Green John L. Chief Financial Officer | Cogent Biosciences, Inc. (COGT) | 25-Feb-21 | Grant | 524 | -- | -- | 2% 21.13K to 21.65K | |
| 07-Dec-20 2:41 PM View: | Green John L. Chief Financial Officer | Cogent Biosciences, Inc. (COGT) | 01-Dec-20 | Grant | 1,748 | -- | -- | 100% 0 to 1.75K | |
| 18-Aug-20 6:19 PM View: | Venrock Healthcare Capital ... 10% Owner | Cogent Biosciences, Inc. (COGT) | 18-Aug-20 | Market Purchase | 101,000 | $2.62 | $264,620.00 | < 1% 12.51M to 12.61M | 21% |
| 18-Aug-20 6:19 PM View: | Venrock Healthcare Capital ... 10% Owner | Cogent Biosciences, Inc. (COGT) | 17-Aug-20 | Market Purchase | 250,000 | $2.57 | $642,500.00 | 2% 12.26M to 12.51M | 24% |
| 18-Aug-20 6:19 PM View: | Venrock Healthcare Capital ... 10% Owner | Cogent Biosciences, Inc. (COGT) | 14-Aug-20 | Market Purchase | 100,000 | $2.30 | $230,000.00 | < 1% 12.16M to 12.26M | 38% |
| 08-Jul-20 7:29 PM View: | Fairmount Funds Management ... 10% Owner | Cogent Biosciences, Inc. (COGT) | 06-Jul-20 | Acquisition (other) | 6,235,900 | -- | -- | 100% 0 to 6.24M | |
| 08-Jul-20 7:40 PM View: | Green John L. Chief Financial Officer | Cogent Biosciences, Inc. (COGT) | 06-Jul-20 | Payment of Exercise | 31,873 | $2.20 | $70,120.60 | (29%) 109.46K to 77.59K | (44%) |
| 08-Jul-20 7:40 PM View: | Green John L. Chief Financial Officer | Cogent Biosciences, Inc. (COGT) | 06-Jul-20 | Option Exercise | 109,459 | -- | -- | 100% 0 to 109.46K | |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 12-May-20 | Market Sale | 98,200 | $0.46 | $45,545.20 | (3%) 3.19M to 3.1M | (577%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 11-May-20 | Market Sale | 100,000 | $0.45 | $45,496.20 | (3%) 3.29M to 3.19M | (592%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 08-May-20 | Market Sale | 100,000 | $0.46 | $46,390.00 | (3%) 3.39M to 3.29M | (585%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 07-May-20 | Market Sale | 100,000 | $0.41 | $41,430.00 | (3%) 3.49M to 3.39M | (674%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 06-May-20 | Market Sale | 1,800 | $0.40 | $721.62 | (< 1%) 3.5M to 3.49M | (695%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 05-May-20 | Market Sale | 135,484 | $0.40 | $54,437.50 | (4%) 3.63M to 3.5M | (689%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 04-May-20 | Market Sale | 4,795 | $0.40 | $1,920.88 | (< 1%) 3.64M to 3.63M | (693%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 01-May-20 | Market Sale | 800 | $0.41 | $328.00 | (< 1%) 3.64M to 3.64M | (663%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 30-Apr-20 | Market Sale | 75,994 | $0.40 | $30,557.20 | (2%) 3.71M to 3.64M | (684%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 29-Apr-20 | Market Sale | 382,927 | $0.41 | $155,507.00 | (9%) 4.1M to 3.71M | (676%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 28-Apr-20 | Market Sale | 15,048 | $0.41 | $6,168.18 | (< 1%) 4.11M to 4.1M | (669%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 27-Apr-20 | Market Sale | 242,579 | $0.40 | $97,807.90 | (6%) 4.35M to 4.11M | (682%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 20-Apr-20 | Market Sale | 12,606 | $0.40 | $5,049.96 | (< 1%) 4.37M to 4.35M | (697%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 17-Apr-20 | Market Sale | 65,540 | $0.39 | $25,573.70 | (1%) 4.43M to 4.37M | (714%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 16-Apr-20 | Market Sale | 600 | $0.38 | $229.56 | (< 1%) 4.43M to 4.43M | (756%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 15-Apr-20 | Market Sale | 82,782 | $0.38 | $31,796.60 | (2%) 4.51M to 4.43M | (763%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 14-Apr-20 | Market Sale | 98,973 | $0.40 | $39,721.10 | (2%) 4.61M to 4.51M | (728%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 09-Apr-20 | Market Sale | 420,292 | $0.33 | $138,150.00 | (8%) 5.03M to 4.61M | (909%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 08-Apr-20 | Market Sale | 100 | $0.35 | $35.10 | (< 1%) 5.03M to 5.03M | (842%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 07-Apr-20 | Market Sale | 11,400 | $0.35 | $3,990.00 | (< 1%) 5.05M to 5.03M | (845%) |
| 08-Oct-20 5:43 PM View: | Campana Dario 10% Owner | Cogent Biosciences, Inc. (COGT) | 06-Apr-20 | Market Sale | 50,080 | $0.35 | $17,528.00 | (< 1%) 5.1M to 5.05M | (828%) |
| 26-Mar-19 4:23 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Mar-19 | Option Exercise | 11,485 | $0.18 | $2,067.30 | 100% 0 to 11.48K | |
| 26-Mar-19 4:23 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Mar-19 | Market Option Sale (Planned) | 11,485 | $4.12 | $47,334.30 | (100%) 11.48K to 0 | 26% |
| 26-Feb-19 10:00 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Feb-19 | Option Exercise | 11,485 | $0.18 | $2,067.30 | 100% 0 to 11.48K | |
| 26-Feb-19 10:00 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Feb-19 | Market Option Sale (Planned) | 11,485 | $4.25 | $48,852.60 | (100%) 11.48K to 0 | 28% |
| 28-Dec-18 7:09 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 26-Dec-18 | Option Exercise | 11,485 | $0.18 | $2,067.30 | 100% 0 to 11.48K | |
| 28-Dec-18 7:09 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 26-Dec-18 | Market Option Sale (Planned) | 11,485 | $4.05 | $46,486.70 | (100%) 11.48K to 0 | 24% |
| 26-Nov-18 7:54 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 26-Nov-18 | Option Exercise | 11,485 | $0.18 | $2,067.30 | 100% 0 to 11.48K | |
| 26-Nov-18 7:54 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 26-Nov-18 | Planned Option Sale | 11,485 | $7.00 | $80,444.40 | (100%) 11.48K to 0 | |
| 29-Oct-18 4:41 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Oct-18 | Option Exercise | 11,485 | $0.18 | $2,067.30 | 100% 0 to 11.48K | |
| 29-Oct-18 4:41 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Oct-18 | Planned Option Sale | 11,485 | $8.46 | $97,201.00 | (100%) 11.48K to 0 | |
| 26-Sep-18 6:41 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Sep-18 | Option Exercise | 11,485 | $0.18 | $2,067.30 | 100% 0 to 11.48K | |
| 26-Sep-18 6:41 PM View: | Ettenberg Seth Chief Scientific Officer | Cogent Biosciences, Inc. (COGT) | 25-Sep-18 | Planned Option Sale | 11,485 | $12.47 | $143,181.00 | (100%) 11.48K to 0 |
